Evidence map›Paper›PMID 26935273›Full record

Trial reportEuropean heart journal2016

Outcomes and costs of left atrial appendage closure from randomized controlled trial and real-world experience relative to oral anticoagulation.

Sandeep Panikker, Joanne Lord, Julian W E Jarman, Shannon Armstrong, David G Jones, Shouvik Haldar, Charles Butcher, Habib Khan, Lilian Mantziari, Edward Nicol and 5 more

Registry-linked trialAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in European heart journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05257954 (Frailty in Patient Undergoing Percutaneous Left Atrial Appendage Closure The Frail-LAAC Study), which is not on this map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05257954 recruitingnot on this mapstarted 2022, after this paper: background citation

Frailty in Patient Undergoing Percutaneous Left Atrial Appendage Closure The Frail-LAAC Study

TypeobservationalSponsorJosep Rodes-CabauRan2022 to 2029Enrolled500ConditionsTranscatheter Left Atrial Appendage Closure, Frailty
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Review
  7. Leap or lag: left atrial appendage closure and guidelines.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
  8. Article
  9. Percutaneous Left Atrial Appendage Occlusion: A View From the UK.Arrhythmia & electrophysiology review · 2020
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Left atrial appendage closure: outcomes and challenges.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2017
    Review
  16. Article
  17. Article
  18. Review
  19. Foam-based Left Atrial Appendage Closure (CLAAS) Device: Evaluation in a Chronic Canine Model.Journal of the Society for Cardiovascular Angiography & Interventions
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Sandeep PanikkerHeart Rhythm Centre, NIHR Cardiovascular Research Unit, Royal Brompton & Harefield Hospitals and National Heart and Lung Institute, Imperial College, Sydney Street, London SW3 6NP, UK.
Joanne LordSouthampton Health Technology Assessments Centre, University of Southampton, Southampton, UK.
Julian W E JarmanHeart Rhythm Centre, NIHR Cardiovascular Research Unit, Royal Brompton & Harefield Hospitals and National Heart and Lung Institute, Imperial College, Sydney Street, London SW3 6NP, UK.
Shannon ArmstrongGfK Bridgehead, Wayland, MA, USA.
David G JonesHeart Rhythm Centre, NIHR Cardiovascular Research Unit, Royal Brompton & Harefield Hospitals and National Heart and Lung Institute, Imperial College, Sydney Street, London SW3 6NP, UK.
Shouvik HaldarHeart Rhythm Centre, NIHR Cardiovascular Research Unit, Royal Brompton & Harefield Hospitals and National Heart and Lung Institute, Imperial College, Sydney Street, London SW3 6NP, UK.
Charles ButcherHeart Rhythm Centre, NIHR Cardiovascular Research Unit, Royal Brompton & Harefield Hospitals and National Heart and Lung Institute, Imperial College, Sydney Street, London SW3 6NP, UK.
Habib KhanHeart Rhythm Centre, NIHR Cardiovascular Research Unit, Royal Brompton & Harefield Hospitals and National Heart and Lung Institute, Imperial College, Sydney Street, London SW3 6NP, UK.
Lilian MantziariHeart Rhythm Centre, NIHR Cardiovascular Research Unit, Royal Brompton & Harefield Hospitals and National Heart and Lung Institute, Imperial College, Sydney Street, London SW3 6NP, UK.
Edward NicolHeart Rhythm Centre, NIHR Cardiovascular Research Unit, Royal Brompton & Harefield Hospitals and National Heart and Lung Institute, Imperial College, Sydney Street, London SW3 6NP, UK.
Wajid HussainHeart Rhythm Centre, NIHR Cardiovascular Research Unit, Royal Brompton & Harefield Hospitals and National Heart and Lung Institute, Imperial College, Sydney Street, London SW3 6NP, UK.
Jonathan R ClagueHeart Rhythm Centre, NIHR Cardiovascular Research Unit, Royal Brompton & Harefield Hospitals and National Heart and Lung Institute, Imperial College, Sydney Street, London SW3 6NP, UK.
John P ForanHeart Rhythm Centre, NIHR Cardiovascular Research Unit, Royal Brompton & Harefield Hospitals and National Heart and Lung Institute, Imperial College, Sydney Street, London SW3 6NP, UK.
Vias MarkidesHeart Rhythm Centre, NIHR Cardiovascular Research Unit, Royal Brompton & Harefield Hospitals and National Heart and Lung Institute, Imperial College, Sydney Street, London SW3 6NP, UK.
Tom WongHeart Rhythm Centre, NIHR Cardiovascular Research Unit, Royal Brompton & Harefield Hospitals and National Heart and Lung Institute, Imperial College, Sydney Street, London SW3 6NP, UK tom.wong@imperial.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThe aim of this study was to analyse randomized controlled study and real-world outcomes of patients with non-valvular atrial fibrillation (NVAF) undergoing left atrial appendage closure (LAAC) with the Watchman device and to compare costs with available antithrombotic therapies. METHODS AND

resultsRegistry data of LAAC from two centres were prospectively collected from 110 patients with NVAF at risk of stroke, suitable and unsuitable for long-term anticoagulation (age 71.3 ± 9.2 years, CHADS

conclusionLeft atrial appendage closure in NVAF in a real-world setting may result in lower stroke and major bleeding rates than reported in LAAC clinical trials. Left atrial appendage closure in both settings achieves cost parity in a relatively short period of time and may offer substantial savings compared with current therapies. Savings are most pronounced among higher risk patients and those unsuitable for anticoagulation.

Indexed as

Atrial AppendageAnticoagulantsAtrial FibrillationHumansStrokeTreatment OutcomeWarfarinAnticoagulantsWarfarinAnticoagulationAtrial fibrillationHealth economicsLeft atrial appendageStroke prevention

Identifiers

PMID26935273
PMCPMC5841215

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.